{"id":"https://openalex.org/W2977422367","doi":null,"title":"The Sydney Classification Criteria for Definite Antiphospholipid Syndrome","display_name":"The Sydney Classification Criteria for Definite Antiphospholipid Syndrome","publication_year":2012,"publication_date":"2012-03-28","ids":{"openalex":"https://openalex.org/W2977422367","mag":"2977422367"},"language":"en","primary_location":{"id":"mag:2977422367","doi":null,"is_oa":false,"landing_page_url":"https://www.rheumatologynetwork.com/fibromyalgia/sydney-classification-criteria-definite-antiphospholipid-syndrome","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101808263","display_name":"Neha Garg","orcid":"https://orcid.org/0000-0001-9206-2046","observed_orcids":["https://orcid.org/0000-0001-9206-2046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neha Garg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9206-2046","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046013095","display_name":"Atul A. Deodhar","orcid":"https://orcid.org/0000-0002-2130-1246","observed_orcids":["https://orcid.org/0000-0002-2130-1246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atul Deodhar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2130-1246","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4039,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.68086688,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":0.9879999756813049},{"id":"https://openalex.org/keywords/sapporo-criteria","display_name":"Sapporo criteria","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antiphospholipid-antibodies","display_name":"antiphospholipid antibodies","score":0.9810000061988831}],"concepts":[{"id":"https://openalex.org/C2776874634","wikidata":"https://www.wikidata.org/wiki/Q582207","display_name":"Antiphospholipid syndrome","level":3,"score":0.7502048015594482},{"id":"https://openalex.org/C2779796141","wikidata":"https://www.wikidata.org/wiki/Q1930430","display_name":"Eleventh","level":2,"score":0.6448277235031128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46966302394866943},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.183637797832489},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16942691802978516},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2977422367","doi":null,"is_oa":false,"landing_page_url":"https://www.rheumatologynetwork.com/fibromyalgia/sydney-classification-criteria-definite-antiphospholipid-syndrome","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2054330426","https://openalex.org/W4387803010","https://openalex.org/W4238383601","https://openalex.org/W7213670017","https://openalex.org/W7134109447","https://openalex.org/W2060080471","https://openalex.org/W2976672456","https://openalex.org/W4386278411","https://openalex.org/W2622146355","https://openalex.org/W4390098969"],"abstract_inverted_index":{"The":[0],"original":[1],"antiphospholipid":[2],"syndrome":[3],"(APS)":[4],"classification":[5],"criteria":[6],"(the":[7],"Sapporo":[8],"criteria),":[9],"published":[10],"in":[11,16,38,41],"1999,":[12],"helped":[13],"galvanize":[14],"research":[15],"this":[17],"disorder.1":[18],"New":[19],"clinical,":[20],"laboratory,":[21],"and":[22],"experimental":[23],"insights":[24],"gained":[25],"since":[26],"then":[27],"were":[28],"addressed":[29],"at":[30],"the":[31],"Eleventh":[32],"International":[33],"Congress":[34],"on":[35],"Antiphospholipid":[36],"Antibodies":[37],"Sydney,":[39],"Australia,":[40],"2006.":[42]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-10-10T00:00:00"}